Serum Neuron-specific Enolase Level As a Biomarker in Differential Diagnosis of Seizure and Syncope

Overview

Journal J Neurol

Specialty Neurology

Date 2010 Jun 10

PMID 20532546

Citations 12

Authors

Seung-Yeob Lee

Young-Chul Choi

Jeong-Ho Kim

Won-Joo Kim

Affiliations

Soon will be listed here.

Abstract

Patients who experience a single generalized tonic-clonic seizure or syncope may have similar clinical symptoms, which can cause difficulty in the differential diagnosis. The aim of this study was to examine whether serum neuron-specific enolase (NSE) has diagnostic relevance as a biochemical marker for these disorders. Serum NSE levels were analyzed following a loss of consciousness in patients who were diagnosed with a seizure (n = 52) and syncope (n = 42) compared with normal controls (n = 91). NSE was 14.97 ± 7.57 ng/dl for the seizure group, 10.15 ± 3.22 ng/dl for the syncope group, and 10.03 ± 1.28 ng/dl for the control group. The seizure group showed a significantly increased serum NSE (p < 0.05) compared to the syncope and control groups. By receiver operating characteristic (ROC) curve analysis, the cut-off value with the highest diagnostic accuracy was defined as 11.5 ng/ml with a sensitivity of 0.58 and specificity of 0.91. The NSE values of the syncope and control groups showed no significant differences. Syncope may not influence diffuse brain damage. Serum NSE measurement may be a helpful test for the identification and diagnosis of a seizure rather than syncope.

Citing Articles

Concordance between the In Vivo Content of Neurospecific Proteins (BDNF, NSE, VILIP-1, S100B) in the Hippocampus and Blood in Patients with Epilepsy.

Tikhonova M, Shvaikovskaya A, Zhanaeva S, Moysak G, Akopyan A, Rzaev J Int J Mol Sci. 2024; 25(1).

PMID: 38203674 PMC: 10779095. DOI: 10.3390/ijms25010502.

Classification Model for Epileptic Seizure Using Simple Postictal Laboratory Indices.

Jin S, Lee T, Moon H, Park E, Lee S, Roh Y J Clin Med. 2023; 12(12).

PMID: 37373723 PMC: 10298879. DOI: 10.3390/jcm12124031.

Bioengineered silkworm model for expressing human neurotrophin-4 with potential biomedical application.

Zhang W, Li Z, Lan W, Guo H, Chen F, Wang F Front Physiol. 2023; 13:1104929.

PMID: 36685209 PMC: 9846172. DOI: 10.3389/fphys.2022.1104929.

Differential Diagnosis of Seizure and Syncope by the Means of Biochemical Markers in Emergency Department Patients.

Masoumi B, Mozafari S, Golshani K, Heydari F, Nasr-Esfahani M Int J Prev Med. 2022; 13:58.

PMID: 35706883 PMC: 9188891. DOI: 10.4103/ijpvm.IJPVM_129_20.

Serum neuron-specific enolase, magnetic resonance imaging, and electrophysiology for predicting neurodevelopmental outcomes of neonates with hypoxic-ischemic encephalopathy: a prospective study.

Huang H, Hu X, Wen X, Yang L BMC Pediatr. 2022; 22(1):290.

PMID: 35581579 PMC: 9112575. DOI: 10.1186/s12887-022-03329-8.

References

Buttner T, Lack B, Jager M, Wunsche W, Kuhn W, Muller T . Serum levels of neuron-specific enolase and s-100 protein after single tonic-clonic seizures. J Neurol. 1999; 246(6):459-61. DOI: 10.1007/s004150050383. View

Sheldon R, Rose S, Ritchie D, Connolly S, Koshman M, Lee M . Historical criteria that distinguish syncope from seizures. J Am Coll Cardiol. 2002; 40(1):142-8. DOI: 10.1016/s0735-1097(02)01940-x. View

Cuthill F, Espie C . Sensitivity and specificity of procedures for the differential diagnosis of epileptic and non-epileptic seizures: a systematic review. Seizure. 2005; 14(5):293-303. DOI: 10.1016/j.seizure.2005.04.006. View

Tumani H, Otto M, Gefeller O, Wiltfang J, Herrendorf G, Mogge S . Kinetics of serum neuron-specific enolase and prolactin in patients after single epileptic seizures. Epilepsia. 1999; 40(6):713-8. DOI: 10.1111/j.1528-1157.1999.tb00768.x. View

Prinz R, Marangos P . Use of neuron-specific enolase as a serum marker for neuroendocrine neoplasms. Surgery. 1982; 92(5):887-9. View

Massabki P, Silva N, Lourenco D, Andrade L . Neuron specific enolase concentration is increased in serum and decreased in platelets of patients with active systemic sclerosis. J Rheumatol. 2004; 30(12):2606-12. View

Berger R, Pierce M, Wisniewski S, Adelson P, Clark R, Ruppel R . Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatrics. 2002; 109(2):E31. DOI: 10.1542/peds.109.2.e31. View

Wijdicks E, Hijdra A, Young G, Bassetti C, Wiebe S . Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2006; 67(2):203-10. DOI: 10.1212/01.wnl.0000227183.21314.cd. View

Marangos P, Schmechel D . Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells. Annu Rev Neurosci. 1987; 10:269-95. DOI: 10.1146/annurev.ne.10.030187.001413. View

10.

Britton J . Syncope and seizures-differential diagnosis and evaluation. Clin Auton Res. 2004; 14(3):148-59. DOI: 10.1007/s10286-004-0184-0. View

11.

Hardemark H, Persson L, Bolander H, Hillered L, Olsson Y, Pahlman S . Neuron-specific enolase is a marker of cerebral ischemia and infarct size in rat cerebrospinal fluid. Stroke. 1988; 19(9):1140-4. DOI: 10.1161/01.str.19.9.1140. View

12.

Chen D, So Y, Fisher R . Use of serum prolactin in diagnosing epileptic seizures: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2005; 65(5):668-75. DOI: 10.1212/01.wnl.0000178391.96957.d0. View

13.

Bandyopadhyay S, Hennes H, Gorelick M, Wells R, Walsh-Kelly C . Serum neuron-specific enolase as a predictor of short-term outcome in children with closed traumatic brain injury. Acad Emerg Med. 2005; 12(8):732-8. DOI: 10.1197/j.aem.2005.02.017. View

14.

Francis A, Rivett A, Roth J . Activity of neuron-specific enolase in normal and lesioned rat brain. Brain Res. 1983; 263(1):89-95. DOI: 10.1016/0006-8993(83)91203-9. View

15.

Rabinowicz A, Correale J, Boutros R, Couldwell W, HENDERSON C, DeGiorgio C . Neuron-specific enolase is increased after single seizures during inpatient video/EEG monitoring. Epilepsia. 1996; 37(2):122-5. DOI: 10.1111/j.1528-1157.1996.tb00002.x. View

16.

McKeon A, Vaughan C, Delanty N . Seizure versus syncope. Lancet Neurol. 2006; 5(2):171-80. DOI: 10.1016/S1474-4422(06)70350-7. View

17.

Petramfar P, Yaghoobi E, Nemati R, Asadi-Pooya A . Serum creatine phosphokinase is helpful in distinguishing generalized tonic-clonic seizures from psychogenic nonepileptic seizures and vasovagal syncope. Epilepsy Behav. 2009; 15(3):330-2. DOI: 10.1016/j.yebeh.2009.04.016. View

18.

Sulter G, Elting J, De Keyser J . Increased serum neuron specific enolase concentrations in patients with hyperglycemic cortical ischemic stroke. Neurosci Lett. 1998; 253(1):71-3. DOI: 10.1016/s0304-3940(98)00595-3. View

19.

Hardemark H, ERICSSON N, Kotwica Z, Rundstrom G, Mendel-Hartvig I, Olsson Y . S-100 protein and neuron-specific enolase in CSF after experimental traumatic or focal ischemic brain damage. J Neurosurg. 1989; 71(5 Pt 1):727-31. DOI: 10.3171/jns.1989.71.5.0727. View

20.

Kohira I, Tsuji T, Ishizu H, Takao Y, Wake A, Abe K . Elevation of neuron-specific enolase in serum and cerebrospinal fluid of early stage Creutzfeldt-Jakob disease. Acta Neurol Scand. 2000; 102(6):385-7. DOI: 10.1034/j.1600-0404.2000.102006385.x. View